Practice Alerts

PDL Practice Alert Tasmania pilot to commence 1st March website image 1

Tasmania pilot to commence 1st March

Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on 1 March 2024. Endorsed pharmacists practising in approved premises

Mitigating risks of the Opioid Therapy Program website image

Mitigating risks of the Opioid Therapy Program

Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to

Administering medicines by injection website image 1

Administering medicines by injection

In recent years, the pharmacy profession has seen significant expansion in the range of medicines that pharmacists can administer by injection. The scope has broadened

Electronic prescriptions website image

Electronic prescriptions

The introduction of electronic prescriptions has improved patient accessibility to medication and reduced the administrative burden on pharmacies related to faxed or emailed prescriptions. Most

PDL Practice Alert NSW regulatory updates website image 2

NSW regulatory updates

Psychostimulant changes The PDL Professional Officers would like to bring to the attention of NSW pharmacists some recent regulatory changes regarding the requirements to prescribe

Medicinal cannabis website image

Medicinal cannabis

The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia. With this emerging field comes the need for comprehensive

Off label prescribing website image 1 1

Off-label prescribing

Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve

Renew your membership now

The market-leading cover for Australian pharmacists, chosen by over 31,000 members.